Viewing Study NCT06073132


Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2026-05-28 @ 4:57 AM
Study NCT ID: NCT06073132
Status: RECRUITING
Last Update Posted: 2025-11-19
First Post: 2023-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)
Sponsor: TWi Biotechnology, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Generalized Epidermolysis Bullosa Simplex View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Epidermolysis Bullosa Simplex View
None EBS View